T

Tianjin Ringpu Bio-Technology Co Ltd
SZSE:300119

Watchlist Manager
Tianjin Ringpu Bio-Technology Co Ltd
SZSE:300119
Watchlist
Price: 18.48 CNY -3.25%
Market Cap: 8.6B CNY
Have any thoughts about
Tianjin Ringpu Bio-Technology Co Ltd?
Write Note

Gross Margin
Tianjin Ringpu Bio-Technology Co Ltd

47.7%
Current
49%
Average
48.4%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
47.7%
=
Gross Profit
1.1B
/
Revenue
2.4B

Gross Margin Across Competitors

Country CN
Market Cap 8.6B CNY
Gross Margin
48%
Country JP
Market Cap 776 550.9T JPY
Gross Margin
-3%
Country US
Market Cap 756.3B USD
Gross Margin
81%
Country UK
Market Cap 440.4B GBP
Gross Margin
56%
Country DK
Market Cap 2.7T DKK
Gross Margin
85%
Country US
Market Cap 349.7B USD
Gross Margin
69%
Country US
Market Cap 251.6B USD
Gross Margin
77%
Country CH
Market Cap 200.1B CHF
Gross Margin
73%
Country UK
Market Cap 161.6B GBP
Gross Margin
82%
Country CH
Market Cap 171.5B CHF
Gross Margin
75%
Country US
Market Cap 151.4B USD
Gross Margin
71%
No Stocks Found

Tianjin Ringpu Bio-Technology Co Ltd
Glance View

Market Cap
8.6B CNY
Industry
Pharmaceuticals

Tianjin Ringpu Bio-Technology Co., Ltd. has carved a niche for itself as a formidable player in the animal health and nutrition industry. Founded in 1998, the company has steadily expanded its portfolio, offering a diverse range of products designed to enhance the health and productivity of livestock and pets. Ringpu's operations are tightly integrated across research, development, production, and sales of veterinary vaccines, medicines, and feed additives. By leveraging cutting-edge biotechnology, Ringpu devises innovative solutions that meet the rigorous standards of animal health care. Its research facilities are at the forefront of developing vaccines that guard against prevalent livestock and pet diseases, ensuring that its offerings remain both effective and relevant. The company's ability to generate revenue hinges on its extensive distribution network and the strategic partnerships it has fostered within China and globally. Ringpu sells its products through a well-established sales force that connects with farmers, livestock producers, and veterinary clinics, providing not just products but also comprehensive health management solutions. Additionally, the company invests heavily in fostering relationships with academic institutions and research bodies, ensuring a steady pipeline of groundbreaking discoveries and innovations. This approach not only bolsters the company's reputation in the industry but also guarantees a sustained stream of income as more clients turn to Ringpu for reliable and sophisticated animal healthcare solutions.

Intrinsic Value
24.96 CNY
Undervaluation 26%
Intrinsic Value
Price
T

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
47.7%
=
Gross Profit
1.1B
/
Revenue
2.4B
What is the Gross Margin of Tianjin Ringpu Bio-Technology Co Ltd?

Based on Tianjin Ringpu Bio-Technology Co Ltd's most recent financial statements, the company has Gross Margin of 47.7%.